Access to skin care and beauty products for cancer patients
Study in Patients With Solid Tumor Regarding Access to Dermo-cosmetics and Aesthetic Solutions
This study looks at how well cancer patients with solid tumors can access skin care and beauty products to help with side effects from their treatments and whether they can afford them.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 210 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Institut de cancérologie Strasbourg Europe Academic / other |
| Locations | 1 site (Strasbourg) |
| Trial ID | NCT05907551 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on patients with solid tumors to assess their knowledge, access, and financial capacity regarding dermo-cosmetics and aesthetic solutions that can help alleviate the side effects of cancer treatments. By utilizing questionnaires, the study aims to gather data on how these products can improve the quality of life for patients experiencing cutaneous, nail, and hair toxicities due to their treatments. The findings may highlight disparities in access to supportive care that is often not covered by health insurance.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old who have been diagnosed with solid tumors and can read and understand French.
Not a fit: Patients who are minors, unable to read French, or under judicial protection will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve access to essential skin care and beauty products for cancer patients, enhancing their quality of life during treatment.
How similar studies have performed: While there may be limited studies specifically addressing access to dermo-cosmetics for cancer patients, the approach of assessing patient knowledge and access to supportive care is increasingly recognized as important in oncology.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \> 18 years * Patients with solid tumors (eligible localization include: digestive system, Head and Neck, Breast, Brain, Lung Tumors, Urological and Gynecologic cancers) * Patients able to read and understand French * Patients that has expressed their consent and with signed consent form Exclusion Criteria: * Minor or patients placed under guardianship or supervision * Patients unable to read French * Patients placed under judicial protection
Where this trial is running
Strasbourg
- Institut de cancérologie Strasbourg Europe — Strasbourg, France (Recruiting)
Study contacts
- Study coordinator: Manon VOEGELIN
- Email: promotion-rc@icans.eu
- Phone: (0)3 68 33 95 23
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.